A new trading day began on Friday, with Marker Therapeutics Inc (NASDAQ: MRKR) stock price up 3.30% from the previous day of trading, before settling in for the closing price of $0.9. MRKR’s price has ranged from $0.81 to $5.95 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 23.96% over the last five years. Meanwhile, its annual earnings per share averaged -26.18%. With a float of $9.20 million, this company’s outstanding shares have now reached $11.30 million.
Marker Therapeutics Inc (MRKR) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Marker Therapeutics Inc is 28.91%, while institutional ownership is 9.76%. The most recent insider transaction that took place on Dec 23 ’24, was worth 35,472. In this transaction Director of this company bought 11,085 shares at a rate of $3.20, taking the stock ownership to the 325,370 shares. Before that another transaction happened on Dec 23 ’24, when Company’s 10% Owner bought 554,250 for $3.20, making the entire transaction worth $1,773,600. This insider now owns 1,625,678 shares in total.
Marker Therapeutics Inc (MRKR) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.26 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -26.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.97% during the next five years compared to 23.96% growth over the previous five years of trading.
Marker Therapeutics Inc (NASDAQ: MRKR) Trading Performance Indicators
Here are Marker Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.73 in one year’s time.
Technical Analysis of Marker Therapeutics Inc (MRKR)
Analysing the last 5-days average volume posted by the [Marker Therapeutics Inc, MRKR], we can find that recorded value of 9.94 million was better than the volume posted last year of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 12.79%.
During the past 100 days, Marker Therapeutics Inc’s (MRKR) raw stochastic average was set at 3.55%, which indicates a significant decrease from 19.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1099 in the past 14 days, which was lower than the 0.1451 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4012, while its 200-day Moving Average is $1.8715. Now, the first resistance to watch is $0.9705. This is followed by the second major resistance level at $1.0152. The third major resistance level sits at $1.0505. If the price goes on to break the first support level at $0.8905, it is likely to go to the next support level at $0.8552. Should the price break the second support level, the third support level stands at $0.8105.
Marker Therapeutics Inc (NASDAQ: MRKR) Key Stats
With a market capitalization of 11.98 million, the company has a total of 12,939K Shares Outstanding. Currently, annual sales are 6,590 K while annual income is -10,730 K. The company’s previous quarter sales were 860 K while its latest quarter income was -4,020 K.
